Rotavirus gastroenteritis in children hospitalized in northeastern Poland in 2006-2020: Severity, seasonal trends, and impact of immunization

Int J Infect Dis. 2021 Jul:108:550-556. doi: 10.1016/j.ijid.2021.05.070. Epub 2021 Jun 3.

Abstract

Objectives: The introduction of the rotavirus vaccine in 2006 significantly reduced childhood incidence of acute gastroenteritis (AGE) worldwide. The rotavirus vaccine was included in Poland's national immunization program in 2021. Our study aimed to summarize the epidemiology of AGE in northeastern Poland prior to 2021 and to evaluate the effectiveness of voluntary, out-of-pocket rotavirus childhood vaccination on the incidence of rotavirus AGE.

Methods: A review of patients aged 0-17 years with gastroenteritis hospitalized between 2006 and 2020 in northeastern Poland in the context of rotavirus vaccine coverage in the region.

Results: Rotavirus was the most common agent of gastroenteritis in hospitalized patients. The seasonality of rotavirus gastroenteritis peaked between February and May in each year of study, except for 2020, when the COVID-19 pandemic skewed any viable comparison of seasonality. Rotavirus vaccine coverage in northeastern Poland did not exceed 25% during the study period and had no impact on hospitalization numbers.

Conclusions: Rotavirus was the primary causative agent of AGE in children hospitalized in northeastern Poland during the study period. Voluntary vaccinations did not affect the number of hospitalizations due to rotavirus AGE. Our data suggest that universal immunization is key to achieving a significant reduction of rotavirus-associated diarrhea.

Keywords: Children; Hospitalization; Rotavirus; Vaccine coverage; Viral gastroenteritis.

Publication types

  • Review

MeSH terms

  • COVID-19*
  • Child
  • Gastroenteritis* / epidemiology
  • Gastroenteritis* / prevention & control
  • Hospitalization
  • Humans
  • Immunization Programs
  • Infant
  • Pandemics
  • Poland / epidemiology
  • Rotavirus Infections* / epidemiology
  • Rotavirus Infections* / prevention & control
  • Rotavirus Vaccines*
  • Rotavirus*
  • SARS-CoV-2
  • Seasons
  • Vaccination
  • Vaccines, Attenuated

Substances

  • Rotavirus Vaccines
  • Vaccines, Attenuated